Connection

VIKAS KUNDRA to Receptors, Vascular Endothelial Growth Factor

This is a "connection" page, showing publications VIKAS KUNDRA has written about Receptors, Vascular Endothelial Growth Factor.
  1. Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. Lancet Oncol. 2011 Nov; 12(12):1109-17.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.